Lexicon Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of LXRX for the last quarter is 1.75 M USD, and it's 6.25% higher compared to the previous quarter. The net income of Q3 24 is -64.81 M USD.